PEGylated systems in pharmaceutics

[thumbnail of 19Aug2020PEGylation review -accepted.pdf]
Preview
Text - Accepted Version
· Please see our End User Agreement before downloading.
| Preview

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Porfiryeva, N. N., Moustafine, R. I. and Khutoryanskiy, V. V. orcid id iconORCID: https://orcid.org/0000-0002-7221-2630 (2020) PEGylated systems in pharmaceutics. Polymer Science Series C, 61 (1). pp. 62-74. ISSN 1811-2382 doi: 10.1134/S181123822001004X

Abstract/Summary

This review addresses the use of poly(ethylene glycol) (PEG) and PEG conjugation for the design of novel dosage forms and the modification of biomolecules. The peculiarities of PEGylated nanoparticles, liposomes, proteins, enzymes, and small drug and polyelectrolyte molecules and their influence on systemic drug delivery, including overcoming of various biological barriers and adhesion to mucosal tissues (mucoadhesion), are considered.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/91652
Identification Number/DOI 10.1134/S181123822001004X
Refereed Yes
Divisions Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmaceutics Research Group
Publisher Springer
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar